LEXINGTON For the past four decades, the University of Kentucky's Sanders-Brown Center on Aging (SBCoA) has been at the ...

For the past four decades, the University of Kentucky’s Sanders-Brown Center on Aging has been at the forefront of Alzheimer’s disease research, making groundbreaking discoveries that have shaped expe ...

Lecanemab and donanemab (Kisunla), another anti-amyloid treatment, won approval based on evidence that they slowed cognitive ...

A world-leading experimental dementia drug designed to prevent the disease before it begins will be trialled in Australia for ...

Campaigners have called for a change in the way treatments for dementia are assessed in the wake of the decision on the drug ...

Donanemab – one of the first drugs to slow down early-stage Alzheimer’s disease – will not be available on the NHS in ...

Royal Melbourne Hospital (RMH) is one of more than a dozen sites around Australia taking part in the major global trial for ...

Walk For A Cure events are family friendly walks for everyone impacted by dementia. By volunteering at Walk For A Cure you will be creating an environment where friends and family can gather together, ...

This groundbreaking research reveals that subtle chemical changes in tau may quietly set off a chain reaction, spreading ...

An estimated 7.2 million Americans aged 65 years and older are living with Alzheimer dementia, and almost all adults feel it is important to diagnose the disease in the early stages.